Order Article Reprints

Ismail J, Klepsch LC, Dahlke P, Tsarenko E, Vollrath A, Pretzel D, Jordan PM, Rezaei K, Czaplewska JA, Stumpf S, et al. PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics. 2024; 16(2):187. https://doi.org/10.3390/pharmaceutics16020187

Ismail, Jana, Lea C. Klepsch, Philipp Dahlke, Ekaterina Tsarenko, Antje Vollrath, David Pretzel, Paul M. Jordan, Kourosh Rezaei, Justyna A. Czaplewska, Steffi Stumpf, and et al. 2024. "PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs" Pharmaceutics 16, no. 2: 187. https://doi.org/10.3390/pharmaceutics16020187

Ismail, J., Klepsch, L. C., Dahlke, P., Tsarenko, E., Vollrath, A., Pretzel, D., Jordan, P. M., Rezaei, K., Czaplewska, J. A., Stumpf, S., Beringer-Siemers, B., Nischang, I., Hoeppener, S., Werz, O., & Schubert, U. S. (2024). PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics, 16(2), 187. https://doi.org/10.3390/pharmaceutics16020187